(Reuters) — Bayer (ETR:BAYN) has short-listed India’s Lupin (NSE:LUPIN) and investor BC Partners as prospective buyers of medical skin cream assets in a potentially €1 billion ($1.1 billion) deal, several people familiar with the sale told Reuters. Germany’s Bayer has for more than 2 years sought to narrow the focus of its healthcare division and its planned $66 billion Monsanto […]
Lupin Pharmaceutical
Lupin, MonoSol Rx ink licensing deal for pediatric products
Lupin Pharmaceutical (NSE:LUPIN) said last week that it inked a licensing agreement with MonoSol Rx to develop pediatric products using MonoSol’s drug delivery technology. Warren, N.J.-based MonoSol touts its dissolvable film, PharmaFilm, as a quick-dissolving system that’s easy to administer and masked by a taste. The minimally invasive film is designed to support pediatric populations that often […]